Ephrin type A receptor 2 (EphA2) is expressed in paediatric sarcomas and paediatric high-grade gliomas (HGGs), glioblastoma multiforme, breast cancer, NSCLC and oesophageal cancer. This evidence concerns the gene EPHA2 and breast cancer.